Post-licensure rapid immunization safety monitoring program (PRISM) data characterization

Meghan A. Baker*, Michael Nguyen, David V. Cole, Grace M. Lee, Tracy A. Lieu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)


The Post-Licensure Rapid Immunization Safety Monitoring (PRISM) program is the immunization safety monitoring component of FDA's Mini-Sentinel project, a program to actively monitor the safety of medical products using electronic health information. FDA sought to assess the surveillance capabilities of this large claims-based distributed database for vaccine safety surveillance by characterizing the underlying data. Methods: We characterized data available on vaccine exposures in PRISM, estimated how much additional data was gained by matching with select state and local immunization registries, and compared vaccination coverage estimates based on PRISM data with other available data sources. We generated rates of computerized codes representing potential health outcomes relevant to vaccine safety monitoring. Standardized algorithms including ICD-9 codes, number of codes required, exclusion criteria and location of the encounter were used to obtain the background rates. Results: The majority of the vaccines routinely administered to infants, children, adolescents and adults were well captured by claims data. Immunization registry data in up to seven states comprised between 5% and 9% of data for all vaccine categories with the exception of 10% for hepatitis B and 3% and 4% for rotavirus and zoster respectively. Vaccination coverage estimates based on PRISM's computerized data were similar to but lower than coverage estimates from the National Immunization Survey and Healthcare Effectiveness Data and Information Set. For the 25 health outcomes of interest studied, the rates of potential outcomes based on ICD-9 codes were generally higher than rates described in the literature, which are typically clinically confirmed cases. Conclusion: PRISM program's data on vaccine exposures and health outcomes appear complete enough to support robust safety monitoring.

Original languageEnglish
Pages (from-to)K98-K112
Issue numberS10
Publication statusPublished - 30 Dec 2013
Externally publishedYes

Bibliographical note

Funding Information:
Contributors: All authors declare that they have participated in: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version submitted. Conflict of interest statement: The authors state they have no conflicts of interest to declare. Funding: Mini-Sentinel is funded by the Food and Drug Administration (FDA) through Department of Health and Human Services (HHS) Contract Number HHSF223200910006I . The views expressed in this document do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.


  • Data characterization
  • Health outcome
  • Mini-Sentinel
  • Surveillance
  • Vaccine


Dive into the research topics of 'Post-licensure rapid immunization safety monitoring program (PRISM) data characterization'. Together they form a unique fingerprint.

Cite this